inetetamab plus vinorelbine (n=212) vs. vinorelbine (n=103)
randomized controlled trial
inetetamab (cipterbin) plus vinorelbine
cipterbin: IV 4 mg/kg loading dose and 2 mg/kg maintenance dose each week / vinorelbine: IV 25 mg/m(2) on days 1,8 and 15 of each 28 days
vinorelbine
vinorelbine: IV 25 mg/m(2) on days 1,8 and 15 of each 28 days
la/mBC - HER2 positive - 2nd Line (L2)
China
Chinese SAP (non-interpretable)
Chinese study. Only data from abstract (in English) are included. Publication and protocole in chinese (non-interpretable - risk of translation error). Results are therefore explorary, and the ROB could not be assessed.